The first membrane-bound reaction of peptidoglycan synthesis in gram-negative and gram-positive organisms is the reaction of the soluble precursor, uridine-diphospho-Nacetylmuramyl -L -alanyl -D -y -glutamyl -(L) -m eso-di amin opim elyl -( L) -D-alanyl-D-alanine (UDP-MurNAc-Ala-Glu-Dap-Ala-Ala), with a C,,-isoprenyl phosphate to give the membranebound intermediate, MurNAc (pentapeptide)-P-P--lipid. UDP-N-acetylglucosamine (UDPGlcNAc) then transfers GlcNAc to give GlcNAc-MurNAc (pentapeptide)-P-P-lipid. The modified disaccharide-peptide unit is then transferred to an acceptor with release of C55-isoprenyl pyrophosphate, which is dephosphorylated to start a new cycle of synthesis. The peptide moiety of this intermediate can then be further modified, e.g., by amidation or by addition of the amino acids of the interpeptide bridge. The resulting oligosaccharide chains are finally modified by transpeptidation to crosslink a portion of the peptide chains, and by D-alanine carboxypeptidase. This yields the final cross-linked cell wall material.
Antibiotics are known which interfere with these pathways at three different places. Vancomycin, ristocetin, ristomycetin (2, 28) , enduracidin (17), moenomycin, prasinomycin, 11, 837 RP (14) , macarbomycin (29) , and several detergents such as deoxycholate and n-octanol (16) dephosphorylation of C,,-isoprenyl pyrophosphate (25) . The penicillins and cephalosporins inhibit transpeptidase and carboxypeptidase activity (2, 28) .
In this investigation, the effects of several lipid-containing antibiotics, diumycin (19) , moenomycin (33), prasinomycin (34) , and janiemycin (21) , as well as the peptide antibiotics nisin (18) and subtilin (9), on peptidoglycan synthesis catalyzed by particulate enzyme preparations from Bacillus stearothermophilus and Escherichia coli were studied. While this work was in progress, the effects of two of these, prasinomycin and moenomycin, were also studied by Lugtenberg et al. (14) . Similarities exist among diumycin, macarbomycin, moenomycin, prasinomycin, and 11,837 RP (6, 15, 20, 27, 29; F. L. Weisenborn, personal communication), between enduracidin and janiemycin (21) , and between nisin and subtilin (3, 4) . In vivo, diumycin (12) , enduracidin (31), macarbomycin (29) , moenomycin (5), prasinomycin (13) 10 mM MgCl2. Cells were broken in a Mini-mill (Gifford-Wood, Hudson, N.Y.) with glass beads, and the membrane fraction was suspended in Tris-hydrochloride-MgCl2 buffer at a concentration of 17 Mg of protein/ml, as described previously for B. megaterium (35) .
The particulate enzyme from E. coli H 102 was a kind gift from T. Kamiryo. It was prepared by alumina grinding (1, 7, 8) min at 37 C, the reaction was stopped by the addition of 10 ,liters of isobutyric acid-1N NH4OH (5:3) and cooled to 0 C. The entire reaction mixture plus washings was spotted on a 1-cm line at the origin of a sheet of Whatman 3MM paper which was then developed by descending chromatography with isobutyric acid-0.125 N NH4OH (5:3). Chromatograms were autoradiographed for 4 days with Kodak RB 54 X-ray film. Areas corresponding to peptidoglycan, UDP-GlcNAc, and GlcNAc-MurNAc (pentapeptide)-P-P-lipid were cut from the paper and counted in 15 ml of toluene-based scintillation fluid. Under these conditions, about 2,400 counts/min were found in peptidoglycan at the origin and about 140 Fig. 1-3 , and antibiotic concentrations giving 50% inhibition of peptidoglycan synthesis are summarized in Table 1 . The antibiotics fell into two classes with regard to their level of effectiveness against peptidoglycan synthesis in vitro. Moenomycin, prasinomycin, and diumycin showed 50% inhibition of peptidoglycan synthesis at concentrations less than 0.1 ug/ml with enzyme preparations from both B. stearothermophilus and E. coli, whereas the 50% inhibitory concentrations for janiemycin, nisin, and subtilin were 20 to 100 /g/ml. Accumulation of the lipid intermediate was found with all of the antibiotics tested except nisin at concentrations at which peptidoglycan synthesis was inhibited with enzyme preparations from both organisms. The radioactivity found in the lipid intermediate was very low for the B. stearothermophilus system, but the accumulation with antibiotics was reproducible and was supported by the more significant data obtained with the E. coli system. (Fig. 4) .
DISCUSSION
In this paper, several additional antibiotic inhibitors of peptidoglycan synthesis are described which were active against preparations from both the gram-negative organism E. coli and the gram-positive organism B. stearothermophilus, viz., diumycin, janiemycin, nisin, and subtilin. In addition, the inhibitory effects of moenomycin and prasinomycin (14) were confirmed. It is of interest that the E. coli cell-free system is as sensitive to diumycin, aEstimated from the data shown in Fig. 1-3 .
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L~ipid moenomycin, and prasinomycin as is that from B. stearothermophilus, since in vivo E. ccli and other gram-negative bacteria are resistant to these antibiotics (19, 32, 34) . These data suggest that the relative resistance of the gram-negative organisms must be due to a permeability barrier. The low concentrations at which diumycin, moenomycin, and prasinomycin inhibit peptidoglycan synthesis in vitro ('0.05 ug/ml) make this site a good candidate for the killing site in vivo and are noteworthy because only penicillins are able to inhibit peptidoglycan synthesis in vitro at such exceedingly low concentrations (7, 8) . Since all of the antibiotics studied here except for nisin induced accumulation of GlcNAc-MurNAc (pentapeptide)-P-P-lipid, the inhibited step or steps of peptidoglycan synthesis must be the step in which this intermediate is utilized for peptidoglycan synthesis. Nisin inhibited synthesis of both lipid intermediate and peptidoglycan. There is no previous example of an antibiotic which does that, although some detergents do (16) . Nisin could be an inhibitor of one of the early steps in peptidoglycan synthesis.
The nonaggregated molecular weights of diumycin A and B, moenomycin, and prasinomycin lie in the range of 1,600 to 2,300 (6, 10, 11).
The concentration of 0.1 gg/ml, at which peptidoglycan synthesis is completely inhibited by these antibiotics, is approximately 50 nM. Since this concentration is at least two orders of magnitude less than that of the UDP- (22, 26, 27, 30) suggest that they are derived from C,2-isoprenyl alcohols, and these antibiotics also contain phosphate. They could conceivably, therefore, function as analogues of C,,-isoprenyl phosphate-containing lipids which function in peptidoglycan synthesis (28) .
